Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Foot Diseases

glucose, (beta-d)-isomer has been researched along with Foot Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ivanovska, N; Kuyumdjieva, A; Neychev, H; Stefanova, Z; Valeva, V1
Calapai, G; Caputi, AP; Cuzzocrea, S; Nava, F; Zingarelli, B1
Gomez, L; Perez, Y; Simpson, BK; Valdivia, A; Villalonga, R1

Other Studies

3 other study(ies) available for glucose, (beta-d)-isomer and Foot Diseases

ArticleYear
Antiinflammatory effect of superoxide dismutase (SOD). Comparison between yeast and bovine SOD on some complement-mediated reactions in vitro and in vivo.
    International journal of tissue reactions, 1994, Volume: 16, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Complement System Proteins; Edema; Enzyme Stability; Foot Diseases; Hemolysis; Immunoglobulin G; Kluyveromyces; Mice; Superoxide Dismutase; Zymosan

1994
Zymosan-activated plasma induces paw oedema by nitric oxide and prostaglandin production.
    Life sciences, 1997, Volume: 60, Issue:3

    Topics: Animals; Arginine; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Edema; Enzyme Inhibitors; Foot Diseases; Hemoglobins; Indomethacin; Inflammation; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Prostaglandins; Rats; Zymosan

1997
Glycosidation of cu,zn-superoxide dismutase with end-group aminated dextran: pharmacological and pharmacokinetics properties.
    Macromolecular bioscience, 2005, Dec-15, Volume: 5, Issue:12

    Topics: Amines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Aspartic Acid; Carbohydrate Sequence; Dextrans; Edema; Enzyme Activation; Foot Diseases; Glucosides; Glutamic Acid; Half-Life; Male; Molecular Sequence Data; Rats; Rats, Wistar; Superoxide Dismutase

2005